Rudi Pauwels

From Wikipedia, the free encyclopedia

Rudi Pauwels (b. 1960) is a Belgian pharmacologist. He studied pharmaceutical sciences at the Catholic University of Leuven, Belgium, and obtained a PhD with a dissertation on Development of New Anti-HIV Agents. He did research on virology at the Rega Institute for Medical Research [1]. In 1994 he founded the Belgian biotech company Tibotec, together with his wife Carine Claeys, and in 1995 he co-founded Virco. In 1999, he was elected as board member of the Flemish Institute for Biotechnology (VIB). Rudi Pauwels now works at the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Lausanne, Switzerland.

[edit] References

  1. ^ Pauwels R, Andries K, Desmyter J, Schols D, Kukla MJ, Breslin HJ, Raeymaeckers A, Van Gelder J, Woestenborghs R, Heykants J, et al., Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives, Nature. 1990 Feb 1;343(6257):470-4

This Belgian biographical article is a stub. You can help Wikipedia by expanding it.